Goro Yoshimura
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Oncology 25
- Cancer Diagnosis and Treatment 9
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
- Bone health and treatments 5
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Qifeng Yang (30 shared papers)Takaomi Suzuma (34 shared papers)Teiji Umemura (34 shared papers)Takeo Sakurai (33 shared papers)Ichiro Mori (24 shared papers)Misa Nakamura (21 shared papers)Yasushi Nakamura (18 shared papers)Kennichi Kakudo (22 shared papers)
- Journals
- Breast Cancer (8 papers)Breast Cancer Research and Treatment (3 papers)Oncology Reports (2 papers)Anti-Cancer Drugs (2 papers)Cancer Research (2 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Goro Yoshimura
52 papers receiving 808 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 274
- Oncology 251
- Pathology and Forensic Medicine 165
- Genetics 202
- Molecular Biology 395
Countries citing papers authored by Goro Yoshimura
This map shows the geographic impact of Goro Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Yoshimura more than expected).
Fields of papers citing papers by Goro Yoshimura
This network shows the impact of papers produced by Goro Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Yoshimura. The network helps show where Goro Yoshimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Goro Yoshimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 78 | |
| 2 | 2001 | 77 | |
| 3 | 2013 | 68 | |
| 4 | 2001 | 53 | |
| 5 | Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. | 2002 | 52 |
| 6 | 1999 | 36 | |
| 7 | 2000 | 35 | |
| 8 | 2002 | 35 | |
| 9 | 2003 | 35 | |
| 10 | 2001 | 34 | |
| 11 | 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. | 2003 | 31 |
| 12 | 2001 | 28 | |
| 13 | Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. | 2001 | 27 |
| 14 | 2001 | 23 | |
| 15 | 2004 | 16 | |
| 16 | 2000 | 16 | |
| 17 | 2003 | 16 | |
| 18 | Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. | 2002 | 16 |
| 19 | 2002 | 16 | |
| 20 | 2002 | 12 |
About Goro Yoshimura
Goro Yoshimura is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 55 papers that have together received 837 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Diagnosis and Treatment (9 papers), Breast Implant and Reconstruction (6 papers), Breast Lesions and Carcinomas (6 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Bone health and treatments (5 papers). The work is most often cited by research in Cancer Research (274 citations), Oncology (251 citations), Pathology and Forensic Medicine (165 citations), Genetics (202 citations) and Molecular Biology (395 citations). Goro Yoshimura has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Qifeng Yang, Takaomi Suzuma, Teiji Umemura, Takeo Sakurai, Ichiro Mori, Misa Nakamura, Yasushi Nakamura, Kennichi Kakudo, Takeshi Tamaki and Yozo Kokawa. Their work appears in journals such as Breast Cancer, Breast Cancer Research and Treatment, Oncology Reports, Anti-Cancer Drugs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.